SCHEMBL5016541

SCHEMBL5016541

CC(N)S(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
CA3 P07451 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
PLA2G7 Q13093 1/20 0.48
CA13 Q8N1Q1 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
HTR6 P50406 2/20 0.46
PSIP1 O75475 1/20 0.44
KDM4E B2RXH2 2/20 0.43
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4004125 0.98 CA12 (0.46) CA12CA1CA2CA9CA3
SCHEMBL4327138 0.80 HTR6 (0.50) CA12CA1CA2CA9CA3
SCHEMBL778854 0.80 HTR6 (0.50) CA12CA1CA2CA9CA3
SCHEMBL3681331 0.79 CA1 (0.54) CA12CA1CA2CA9CA3
SCHEMBL4838318 0.78 GAA (0.41) CA12CA1CA2CA9CA4
SCHEMBL3328703 0.78 HTR6 (0.48) CA12CA1CA2CA9CA3
SCHEMBL21515839 0.77 CA1 (0.52) CA12CA1CA2CA9CA3
SCHEMBL2446838 0.77 PSIP1 (0.52) HTR6PSIP1KDM4ESMN1; SMN2ALDH1A1
SCHEMBL25001334 0.76 HTR6 (0.46) CA12CA1CA2CA9CA3
SCHEMBL3328706 0.76 TSHR (0.48) CA12CA1CA2CA9CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107722043-B Preparation method of chiral amino compound and intermediate thereof 上海彩迩文生化科技有限公司 2021-03-05 CN disclosed
EP-1896014-A2 CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-03-12 EP disclosed
US-20070087295-A1 RADIOGRAPHIC MATERIALS WITH ANTIFOGGANT PRECURSORS EASTMAN KODAK COMPANY 2007-04-19 US disclosed
WO-2007005534-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-01-11 WO disclosed
EP-1727526-A2 PIPERAZINE UREA DERIVATIVES FOR THE TREATMENT OF ENDOMETRIOSIS Schering Aktiengesellschaft (DE) 2006-12-06 EP disclosed
WO-2005079769-A2 PIPERAZINE DERIVATIVES FOR THE TREATMENT OF ENDOMETRIOSIS SCHERING AKTIENGESELLSCHAFT (DE) 2005-09-01 WO disclosed
EP-1214322-A2 AMINO-TRIAZOLOPYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-06-19 EP disclosed
WO-2001017999-A2 AMINO-TRIAZOLOPYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-03-15 WO disclosed